Apremilast

Home > API & Intermediate > Drug Metabolism > Apremilast Manufacturers > Apremilast

Apremilast

CAS NO.： 608141-41-9

FOB Price： NEGOTIABLE Get Latest Price

Specification： 99.0%

Documentation： Get COA after inquiry

Lead Time： 14-30 days

Max Capacity： -

Packing： 25KG/Fibre Drum

Product Detail

Properties

Product Name：Apremilast

CAS:608141-41-9

Purity：99.0%

Inside Code：AMT03

Structural formula：

Apremilast was developed by celgene biotechnology in the United States and approved by the U.S. Food and Drug Administration (FDA) on March 21, 2014 for the treatment of adult active psoriatic arthritis (PSA).

Properties

Apremilast is an oral phosphodiesterase 4 inhibitor is used in the treatment of psoriatic arthritis.

CAS No.

608141-41-9

Formula

C22H24N2O7S

Molecular Mass

460.5

Exact Mass

460.13000

PSA

127.46000

Logp

3.52590

IUPAC

N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl]acetamide

Category

Density

1.381

Boiling Point

741.3±60.0 °C(Predicted)

Appearance

White to grayish white solid

HS Code

UN No.

DG-Class

Send your message to this supplier

To：

Zhongshan Enantiotech Corporation Limited

Not exactly what you want? One request, multiple quotations Get Quotations Now >>

Supplier's main products

N-Methylcarbonyl-2-chloroacetamidrazone

5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,4-c]Pyridine-2-Carboxylic acid Hydrochloride

Zhongshan Enantiotech Corporation Limited

17YRS

Business Type：

CRO

Country/Region：

Guangdong, China

Contacts：

Manager Wang

Position Title：

Sales Manager

Tel：

0086-760-85282375

Email：

enantiotech@chemmail.net

Visit Factory

Get Free Samples

Less than 1KG required

b

Send Email